0	The cloning of a complementary DNA encoding a human PROTEIN TAF , PROTEIN1 , that has no known homolog in Drosophila PROTEIN2 is now described .
0	PROTEIN is shown to interact with the largest subunit ( PROTEIN1 ) of human PROTEIN through its central region and with multiple activators -- including PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , adenoviral PROTEIN , and human immunodeficiency virus-type 1 PROTEIN proteins -- through a distinct amino-terminal domain .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants PROTEIN1PROTEIN2 in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and Fas-FD8 .
1	In resting human epithelial and fibroblastic cells , PROTEIN1 is phosphorylated on serine and threonine at five sites , three of which are phosphorylated in vitro by glycogen synthase kinase 3 ( PROTEIN2 ) .
0	PROTEIN also interacted with PROTEIN and PROTEIN and with the dominant inhibitors PROTEIN and Bcl-X-S. PROTEIN1 displayed the same pattern of combinatorial interactions with PROTEIN2 family proteins as PROTEIN .
1	Expressed in a murine myeloma , PROTEIN1 was identified as a ligand for PROTEIN by binding to a soluble PROTEIN2 construct .
0	Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ( PROTEIN ) protein PROTEIN1 and the pocket proteins PROTEIN , PROTEIN and pRb2/PROTEIN2 .
1	The six most frequently observed PROTEIN1 mutations disrupt PROTEIN2 binding in vitro .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN1PROTEIN2-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	PROTEIN is shown to interact with the largest subunit ( PROTEIN ) of human PROTEIN1 through its central region and with multiple activators -- including PROTEIN , PROTEIN , PROTEIN , PROTEIN , adenoviral PROTEIN2 , and human immunodeficiency virus-type 1 PROTEIN proteins -- through a distinct amino-terminal domain .
1	The PROTEIN1-interacting region of PROTEIN2 was localized to its DNA-binding domain , which is distinct from the glutamine-rich activation domains previously shown to interact with Drosophila PROTEIN .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN1 , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants PROTEIN2-LPR and Fas-FD8 .
0	Overexpression of PROTEIN in MCF7 and BJAB cells induces apoptosis , which , like Fas-induced apoptosis , is blocked by PROTEIN , a specific inhibitor of the PROTEIN1PROTEIN2 in MCF7 and BJAB cells induces apoptosis , which , like Fas-induced apoptosis , is blocked by PROTEIN , a specific inhibitor of the interleukin-1 beta-converting enzyme .
1	Residues in human leukemia inhibitory factor ( PROTEIN1 ) crucial for binding to both the human LIF receptor ( R ) and PROTEIN2 were identified by analysis of alanine scanning mutants of PROTEIN in assays for both receptor binding and bioactivity .
0	We further showed that PROTEIN1 was comodulated on the T cell surface with PROTEIN2 , a known membrane-linked protein tyrosine phosphatase and that anti-CD26 was capable of precipitating PROTEIN from T cell lysates .
0	PROTEIN is shown to interact with the largest subunit ( PROTEIN ) of human PROTEIN through its central region and with multiple activators -- including PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , adenoviral PROTEIN , and human immunodeficiency virus-type 1 PROTEIN2 proteins -- through a distinct amino-terminal domain .
0	PROTEIN also interacted with PROTEIN and PROTEIN1 and with the dominant inhibitors PROTEIN and PROTEIN2 .
1	Thus , during myogenic differentiation , formation of PROTEIN1 and pRb2/PROTEIN2 containing complexes is an early event , but not enough on its own to prevent the reactivation of DNA synthesis .
0	Interaction of the PROTEIN subunit of PI 3-kinase with the PROTEIN receptor ( PROTEIN ) and the PROTEIN1 receptor ( PROTEIN2 ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
0	An PROTEIN complex containing mainly PROTEIN and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( PROTEIN1PROTEIN2 complex of proliferating myoblasts ( E2F-G1/S complex ) .
1	Interaction of the PROTEIN subunit of PROTEIN1 with the PROTEIN receptor ( PROTEIN ) and the PROTEIN2 ( PROTEIN ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
0	Interaction of PROTEIN subunit of PI 3-kinase with PROTEIN and PROTEIN1PROTEIN2 with PROTEIN and PROTEIN receptors analysed by using the two-hybrid system .
0	Using the cytoplasmic domain of PROTEIN1 in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and Fas-PROTEIN2 .
0	Activation of lacZ upon interaction of PROTEIN with PROTEIN beta ( delta C-43 ) was 4-fold less as compared to PROTEIN1PROTEIN2 ) was 4-fold less as compared to PROTEIN beta .
1	The results of his3 activation indicated that PROTEIN1 , N + C-SH2 and C-SH2 interact with both PROTEIN beta and PROTEIN2 , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN beta .
0	PROTEIN is shown to interact with the largest subunit ( PROTEIN1 ) of human PROTEIN2 through its central region and with multiple activators -- including PROTEIN , PROTEIN , PROTEIN , PROTEIN , adenoviral PROTEIN , and human immunodeficiency virus-type 1 PROTEIN proteins -- through a distinct amino-terminal domain .
0	An PROTEIN complex containing mainly PROTEIN and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/PROTEIN1PROTEIN2 and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	Interaction of PROTEIN and N+C-SH2 with PROTEIN beta ( PROTEIN1PROTEIN2 and N+C-SH2 with PROTEIN beta ( delta C-43 ) or PROTEIN beta ( delta C-43 ) in which the C-terminal 43 amino acids ( including the YXXM motif ) were deleted , persisted .
0	Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN1 ( PROTEIN ) protein PROTEIN and the pocket proteins PROTEIN , PROTEIN and PROTEIN2/p130 .
0	An PROTEIN complex containing mainly PROTEIN and PROTEIN1/PROTEIN2 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
1	Residues in human leukemia inhibitory factor ( PROTEIN1 ) crucial for binding to both the human PROTEIN2 ( R ) and PROTEIN were identified by analysis of alanine scanning mutants of PROTEIN in assays for both receptor binding and bioactivity .
0	PROTEIN1 binds exclusively to the underphosphorylated form of PROTEIN and fails to bind to PROTEIN2 mutants derived from patients with PROTEIN .
0	Interactions of the PROTEIN protein with itself and other members of the PROTEIN family , including PROTEIN , PROTEIN , PROTEIN , and PROTEIN1PROTEIN2 family , including PROTEIN , PROTEIN , PROTEIN , and PROTEIN , were explored with a yeast two-hybrid system .
0	The results of his3 activation indicated that PROTEIN , N + C-SH2 and C-SH2 interact with both PROTEIN1 and PROTEIN2 beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN beta .
0	This activation with PROTEIN and PROTEIN beta was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN beta ( PROTEIN1PROTEIN2 beta ( delta C-43 ) .
0	Whereas PROTEIN serves as an alternative accessory protein to the common cytokine receptor gamma chain ( PROTEIN1 ) for PROTEIN signaling , it could not replace the function of PROTEIN2 in allowing enhanced PROTEIN binding activity .
0	This activation with PROTEIN and PROTEIN beta was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN beta ( PROTEIN1PROTEIN2 and PROTEIN beta was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN beta ( delta C-43 ) .
1	Thus , PROTEIN1 encodes a human FGF receptor with high affinity for both PROTEIN and PROTEIN2 .
0	PROTEIN prevents cyclinA/cdk2 containing PROTEIN1PROTEIN2/cdk2 containing PROTEIN complexes formation in terminally differentiated myocytes .
0	Overexpression of PROTEIN in MCF7 and BJAB cells induces apoptosis , which , like Fas-induced apoptosis , is blocked by PROTEIN , a specific inhibitor of the PROTEIN1PROTEIN2 in MCF7 and BJAB cells induces apoptosis , which , like Fas-induced apoptosis , is blocked by PROTEIN , a specific inhibitor of the interleukin-1 beta-converting enzyme .
1	The region of PROTEIN1 most important for binding to the PROTEIN2 is composed of residues from the amino terminus of the D-helix , carboxyl terminus of the B-helix , and C-D loop .
0	An PROTEIN complex containing mainly PROTEIN and pRb2/PROTEIN1 ( PROTEIN2-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	Use of deletion mutants of PROTEIN suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN protein , since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN1PROTEIN2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN amino acids 83-218 .
0	PROTEIN1 contains a death domain homologous to the death domains of PROTEIN and PROTEIN2 .
1	PROTEIN1 is shown to interact with the largest subunit ( PROTEIN2 ) of human PROTEIN through its central region and with multiple activators -- including PROTEIN , PROTEIN , PROTEIN , PROTEIN , adenoviral PROTEIN , and human immunodeficiency virus-type 1 PROTEIN proteins -- through a distinct amino-terminal domain .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN1PROTEIN2 , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN1 and Fas-FD5 , a mutant of PROTEIN2 possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and Fas-FD8 .
0	Thus , the C-terminal domain in PROTEIN1 appears to exert a negative control on binding of PROTEIN thereby providing a possible regulatory mechanism for direct activation of the PROTEIN2 pathway .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN2 ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	In the present report , we demonstrated that modulation of PROTEIN from T cell surface induced by antiCD26 ( 1F7 ) led to enhanced phosphorylation of PROTEIN zeta tyrosine residues and increased PROTEIN1PROTEIN2 ( 1F7 ) led to enhanced phosphorylation of PROTEIN zeta tyrosine residues and increased PROTEIN associated p56lck tyrosine kinase activity .
0	Interactions of the PROTEIN protein with itself and other members of the PROTEIN family , including PROTEIN , PROTEIN , PROTEIN , and PROTEIN1PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , were explored with a yeast two-hybrid system .
0	This activation with PROTEIN and PROTEIN beta was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN1PROTEIN2 and PROTEIN beta was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN beta ( delta C-43 ) .
0	These findings strongly suggest that PROTEIN1 may be closely associated with the PROTEIN protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of PROTEIN2 with PROTEIN results in enhanced tyrosine kinase activity , zeta chain phosphorylation , and T cell activation .
0	Interaction of PROTEIN1 subunit of PI 3-kinase with PROTEIN2 and PROTEIN receptors analysed by using the two-hybrid system .
0	This cytotoxicity could be abrogated by B42 fusion proteins containing PROTEIN , PROTEIN , or PROTEIN but not those containing PROTEIN1PROTEIN2 , or PROTEIN but not those containing PROTEIN ( an alternatively spliced form of PROTEIN that lacks a well-conserved 63-amino acid region ) .
0	PROTEIN also interacted with PROTEIN1 and PROTEIN and with the dominant inhibitors PROTEIN and PROTEIN2 .
1	From Scatchard analyses , the Kd : s for binding of PROTEIN1 and PROTEIN to PROTEIN2 were estimated to 25 pM and 41 pM , respectively .
0	Interactions of the PROTEIN protein with itself and other members of the PROTEIN family , including PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN , were explored with a yeast two-hybrid system .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-PROTEIN1PROTEIN2-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN1 possessing enhanced killing activity , but not the functionally inactive mutants Fas-PROTEIN2 and Fas-FD8 .
0	The results of his3 activation indicated that PROTEIN , N + C-SH2 and C-SH2 interact with both PROTEIN beta and PROTEIN1PROTEIN2 beta and PROTEIN beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN beta .
0	PROTEIN also interacted with PROTEIN1 and PROTEIN2 and with the dominant inhibitors PROTEIN and Bcl-X-S. PROTEIN displayed the same pattern of combinatorial interactions with PROTEIN family proteins as PROTEIN .
1	Interaction of the PROTEIN subunit of PROTEIN1 with the PROTEIN receptor ( PROTEIN ) and the PROTEIN receptor ( PROTEIN2 ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
0	Interaction of PROTEIN subunit of PI 3-kinase with PROTEIN and PROTEIN1PROTEIN2 and PROTEIN receptors analysed by using the two-hybrid system .
0	Interaction of the PROTEIN subunit of PI 3-kinase with the PROTEIN receptor ( PROTEIN ) and the PROTEIN1PROTEIN2 ( PROTEIN ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
0	Interaction of PROTEIN and N+C-SH2 with PROTEIN beta ( delta C-43 ) or PROTEIN beta ( PROTEIN1PROTEIN2 ( delta C-43 ) or PROTEIN beta ( delta C-43 ) in which the C-terminal 43 amino acids ( including the YXXM motif ) were deleted , persisted .
0	Interaction of the PROTEIN subunit of PROTEIN1PROTEIN2 subunit of PI 3-kinase with the PROTEIN receptor ( PROTEIN ) and the PROTEIN receptor ( PROTEIN ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN1PROTEIN2 , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	Use of deletion mutants of PROTEIN1 suggested that PROTEIN2 homodimerization involves interactions between two distinct regions within the PROTEIN protein , since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN amino acids 83-218 .
0	PROTEIN is shown to interact with the largest subunit ( PROTEIN ) of human PROTEIN1PROTEIN2 is shown to interact with the largest subunit ( PROTEIN ) of human PROTEIN through its central region and with multiple activators -- including PROTEIN , PROTEIN , PROTEIN , PROTEIN , adenoviral PROTEIN , and human immunodeficiency virus-type 1 PROTEIN proteins -- through a distinct amino-terminal domain .
0	In differentiating C2C12 cells , PROTEIN complexes switch and DNA synthesis in response to serum are prevented when PROTEIN DNA binding activity and the cdks inhibitor PROTEIN1PROTEIN2 DNA binding activity and the cdks inhibitor PROTEIN downstream effector PROTEIN are induced .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN1PROTEIN2 ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
1	Interactions of the PROTEIN1 protein with itself and other members of the PROTEIN family , including PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , were explored with a yeast two-hybrid system .
0	The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN function , and indicate that requirements for Bcl-2/PROTEIN1PROTEIN2 and PROTEIN differentially regulate PROTEIN function , and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization .
1	Interaction of PROTEIN1 and N+C-SH2 with PROTEIN beta ( delta C-43 ) or PROTEIN2 ( delta C-43 ) in which the C-terminal 43 amino acids ( including the YXXM motif ) were deleted , persisted .
0	Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ( PROTEIN1 ) protein PROTEIN and the pocket proteins PROTEIN , PROTEIN and PROTEIN2/p130 .
0	Use of deletion mutants of PROTEIN suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN protein , since a LexA protein containing PROTEIN1PROTEIN2 protein , since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN amino acids 83-218 .
1	Phosphorylation of recombinant human PROTEIN1 proteins in vitro by PROTEIN2 decreases their DNA-binding activity .
0	The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN function , and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for PROTEIN1PROTEIN2 heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization .
0	Nevertheless , the overall size and length of the cytoplasmic domain of PROTEIN and PROTEIN are similar , and like PROTEIN1PROTEIN2 are similar , and like PROTEIN , PROTEIN is located on chromosome X .
0	The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN function , and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/PROTEIN1PROTEIN2 heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization .
0	This cytotoxicity could be abrogated by B42 fusion proteins containing PROTEIN , PROTEIN1 , or PROTEIN but not those containing PROTEIN ( an alternatively spliced form of PROTEIN2 that lacks a well-conserved 63-amino acid region ) .
0	This activation with PROTEIN and PROTEIN beta was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN beta ( PROTEIN1PROTEIN2 and was somewhat increased ( 2-fold ) for PROTEIN beta ( delta C-43 ) .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN1PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	Interaction of PROTEIN and N+C-SH2 with PROTEIN beta ( delta C-43 ) or PROTEIN beta ( PROTEIN1PROTEIN2 and N+C-SH2 with PROTEIN beta ( delta C-43 ) or PROTEIN beta ( delta C-43 ) in which the C-terminal 43 amino acids ( including the YXXM motif ) were deleted , persisted .
0	The results of his3 activation indicated that PROTEIN1 , N + C-SH2 and C-SH2 interact with both PROTEIN beta and PROTEIN2 beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN beta .
0	The results of his3 activation indicated that PROTEIN , N + C-SH2 and C-SH2 interact with both PROTEIN beta and PROTEIN beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN1PROTEIN2 beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN beta .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN1PROTEIN2 ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
1	A cDNA encoding part of the PROTEIN1 protein sequence interacted with the PROTEIN2 basic-helix-loop-helix only when fused to a beta-galactosidase tag .
1	The crystal structure of the PROTEIN1 core domain bound to the PROTEIN2 protein , which contains an SH3 ( Src homology 3 ) domain and four ankyrin repeats , revealed that ( i ) the SH3 domain binds the L3 loop of PROTEIN in a manner distinct from that of previously characterized SH3-polyproline peptide complexes , and ( ii ) an ankyrin repeat , which forms an L-shaped structure consisting of a beta hairpin and two alpha helices , binds the L2 loop of PROTEIN .
0	The results of his3 activation indicated that PROTEIN , N + C-SH2 and C-SH2 interact with both PROTEIN beta and PROTEIN1PROTEIN2 and PROTEIN beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN beta .
0	An PROTEIN1 complex containing mainly PROTEIN and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the PROTEIN2/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN1PROTEIN2-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	Interaction of PROTEIN and N+C-SH2 with PROTEIN beta ( PROTEIN1PROTEIN2 ( delta C-43 ) or PROTEIN beta ( delta C-43 ) in which the C-terminal 43 amino acids ( including the YXXM motif ) were deleted , persisted .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN1PROTEIN2 ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
1	PROTEIN1 associates with the PROTEIN2 after ligand stimulation , and binding of PROTEIN to this receptor promotes tyrosine phosphorylation of PROTEIN .
0	Interaction of PROTEIN and N+C-SH2 with PROTEIN beta ( delta C-43 ) or PROTEIN1PROTEIN2 ( delta C-43 ) or PROTEIN beta ( delta C-43 ) in which the C-terminal 43 amino acids ( including the YXXM motif ) were deleted , persisted .
0	PROTEIN is shown to interact with the largest subunit ( PROTEIN1 ) of human PROTEIN through its central region and with multiple activators -- including PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , adenoviral PROTEIN , and human immunodeficiency virus-type 1 PROTEIN proteins -- through a distinct amino-terminal domain .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-PROTEIN1PROTEIN2 and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and Fas-FD8 .
0	Use of deletion mutants of PROTEIN suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN protein , since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN1PROTEIN2 amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN amino acids 83-218 .
0	Regulation of the PROTEIN1-related transcription factor PROTEIN by binding to the PROTEIN2 protein .
0	Interaction of the PROTEIN subunit of PI 3-kinase with the PROTEIN1PROTEIN2 ( PROTEIN ) and the PROTEIN receptor ( PROTEIN ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
0	In the present report , we demonstrated that modulation of PROTEIN from T cell surface induced by antiCD26 ( 1F7 ) led to enhanced phosphorylation of PROTEIN1 zeta tyrosine residues and increased PROTEIN2 associated p56lck tyrosine kinase activity .
0	Interaction of the PROTEIN subunit of PI 3-kinase with the PROTEIN1 ( PROTEIN2 ) and the PROTEIN receptor ( PROTEIN ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-PROTEIN1 ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN2/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
1	A second region of PROTEIN1 that includes residues from the carboxyl terminus of the D-helix and A-B loop also had a weak influence on PROTEIN2 binding .
0	The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN function , and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/PROTEIN1PROTEIN2 differentially regulate PROTEIN function , and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization .
1	The structure of the PROTEIN1-PROTEIN2-heparin ternary complex provides a structural basis for the essential role of heparan sulphate in FGF signalling .
1	PROTEIN1 is shown to interact with the largest subunit ( PROTEIN ) of human PROTEIN through its central region and with multiple activators -- including PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , adenoviral PROTEIN , and human immunodeficiency virus-type 1 PROTEIN proteins -- through a distinct amino-terminal domain .
1	Structure of the PROTEIN1 tumor suppressor bound to the ankyrin and SH3 domains of PROTEIN2 .
1	Interactions of the PROTEIN1 protein with itself and other members of the PROTEIN family , including PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 , were explored with a yeast two-hybrid system .
0	An PROTEIN complex containing mainly PROTEIN and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/PROTEIN1PROTEIN2 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ( PROTEIN1PROTEIN2 ( PROTEIN ) protein PROTEIN and the pocket proteins PROTEIN , PROTEIN and pRb2/p130 .
0	Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN1 ( PROTEIN ) protein PROTEIN and the pocket proteins PROTEIN , PROTEIN2 and pRb2/p130 .
0	This activation with PROTEIN and PROTEIN beta was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN1PROTEIN2 beta was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN beta ( delta C-43 ) .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN1 possessing enhanced killing activity , but not the functionally inactive mutants PROTEIN2-LPR and Fas-FD8 .
0	The results of his3 activation indicated that PROTEIN , N + C-SH2 and C-SH2 interact with both PROTEIN beta and PROTEIN beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN1PROTEIN2 , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN beta .
0	An PROTEIN1 complex containing mainly PROTEIN and pRb2/p130 ( PROTEIN2-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
1	Activation of lacZ upon interaction of PROTEIN1 with PROTEIN2 ( delta C-43 ) was 4-fold less as compared to PROTEIN beta .
1	Using epitope-tagging , interaction of PROTEIN1 basic-helix-loop-helix protein with the PROTEIN2 protein encoded by this novel cDNA was confirmed by immunoprecipitation experiments in COS7 cells .
0	PROTEIN is shown to interact with the largest subunit ( PROTEIN ) of human PROTEIN1 through its central region and with multiple activators -- including PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , adenoviral PROTEIN , and human immunodeficiency virus-type 1 PROTEIN proteins -- through a distinct amino-terminal domain .
1	From Scatchard analyses , the Kd : s for binding of PROTEIN and PROTEIN1 to PROTEIN2 were estimated to 25 pM and 41 pM , respectively .
0	PROTEIN is shown to interact with the largest subunit ( PROTEIN1 ) of human PROTEIN through its central region and with multiple activators -- including PROTEIN , PROTEIN , PROTEIN , PROTEIN , adenoviral PROTEIN , and human immunodeficiency virus-type 1 PROTEIN2 proteins -- through a distinct amino-terminal domain .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN1PROTEIN2-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and PROTEIN1-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants PROTEIN2-LPR and Fas-FD8 .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN1 containing complex following serum stimulation and this correlates with suppression of PROTEIN2 activity and the inability of cells to re-enter the cell cycle .
1	In this report , it is demonstrated that PROTEIN1 contains a sequence motif that is highly related to the PROTEIN binding sites of several viral oncoproteins and binds to the pocket region of PROTEIN2 both in vitro and in vivo .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN1PROTEIN2/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	This activation with PROTEIN and PROTEIN1PROTEIN2 beta was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN beta ( delta C-43 ) .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN1PROTEIN2 ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	Overexpression of a phosphorylation-defective form of PROTEIN1 inhibited PROTEIN2-dependent transcription during T cell activation .
1	The structure of the complex shows that the PROTEIN1 binding site on the PROTEIN2 core domain consists of evolutionarily conserved regions that are frequently mutated in cancer and that it overlaps the site of DNA binding .
0	The results of his3 activation indicated that PROTEIN , N + C-SH2 and C-SH2 interact with both PROTEIN beta and PROTEIN beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN1PROTEIN2 beta .
0	Interactions of the PROTEIN protein with itself and other members of the PROTEIN family , including PROTEIN , PROTEIN , PROTEIN1PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , were explored with a yeast two-hybrid system .
0	The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN function , and indicate that requirements for PROTEIN1PROTEIN2 function , and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization .
0	PROTEIN is shown to interact with the largest subunit ( PROTEIN ) of human PROTEIN through its central region and with multiple activators -- including PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , adenoviral PROTEIN , and human immunodeficiency virus-type 1 PROTEIN proteins -- through a distinct amino-terminal domain .
1	Using a protein interaction cloning technique , we identified cDNAs that encode a novel PROTEIN1-binding protein , termed PROTEIN2 .
0	Whereas PROTEIN serves as an alternative accessory protein to the common PROTEIN1 ( PROTEIN ) for PROTEIN signaling , it could not replace the function of PROTEIN in allowing enhanced PROTEIN2 binding activity .
0	Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ( PROTEIN ) protein PROTEIN1 and the pocket proteins PROTEIN , PROTEIN2 and pRb2/p130 .
0	Interaction of the PROTEIN1 subunit of PI 3-kinase with the PROTEIN receptor ( PROTEIN ) and the PROTEIN receptor ( PROTEIN2 ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
1	Here we show that beta : PROTEIN1 binds to the activin type II receptor kinase ( PROTEIN2 ) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta : beta .
0	Interaction of the PROTEIN subunit of PROTEIN1 with the PROTEIN2 receptor ( PROTEIN ) and the PROTEIN receptor ( PROTEIN ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
0	An PROTEIN1 complex containing mainly PROTEIN2 and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	The crystal structure of the PROTEIN core domain bound to the PROTEIN protein , which contains an SH3 ( Src homology 3 ) domain and four ankyrin repeats , revealed that ( i ) the SH3 domain binds the L3 loop of PROTEIN1 in a manner distinct from that of previously characterized SH3-polyproline peptide complexes , and ( ii ) an ankyrin repeat , which forms an L-shaped structure consisting of a beta hairpin and two alpha helices , binds the L2 loop of PROTEIN2 .
0	Thus , the C-terminal domain in PROTEIN appears to exert a negative control on binding of PROTEIN1 thereby providing a possible regulatory mechanism for direct activation of the PROTEIN2 pathway .
0	An PROTEIN complex containing mainly PROTEIN and PROTEIN1/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the PROTEIN2/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	These results demonstrate that PROTEIN interacts specifically with a lineage-restricted PROTEIN1PROTEIN2 interacts specifically with a lineage-restricted PROTEIN transcription factor .
0	We further showed that PROTEIN was comodulated on the T cell surface with PROTEIN , a known membrane-linked protein tyrosine phosphatase and that anti-CD26 was capable of precipitating PROTEIN1PROTEIN2 , a known membrane-linked protein tyrosine phosphatase and that anti-CD26 was capable of precipitating PROTEIN from T cell lysates .
1	The catalytic domain of activated PROTEIN I ( PROTEIN1 ) is absolutely required for interaction with its specific inhibitor , PROTEIN2 ( TIMP-1 ) .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-PROTEIN1PROTEIN2-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	This cytotoxicity could be abrogated by B42 fusion proteins containing PROTEIN , PROTEIN , or PROTEIN1PROTEIN2 , or PROTEIN but not those containing PROTEIN ( an alternatively spliced form of PROTEIN that lacks a well-conserved 63-amino acid region ) .
0	The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN1 function , and indicate that requirements for Bcl-2/PROTEIN2 heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization .
0	PROTEIN is highly similar to an identified murine PROTEIN ligand both at the cDNA ( 82.8 % identity ) and the protein ( 77.4 % identity ) levels , and related to tumor necrosis factor/PROTEIN1PROTEIN2 is highly similar to an identified murine PROTEIN ligand both at the cDNA ( 82.8 % identity ) and the protein ( 77.4 % identity ) levels , and related to tumor necrosis factor/lymphotoxin .
0	After T cell activation , the phosphorylation of PROTEIN1 results in the release of PROTEIN2 , which is correlated temporally with the activation of Elf-1-mediated transcription .
1	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN1 , which binds PROTEIN2 and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and Fas-FD8 .
0	After T cell activation , the phosphorylation of PROTEIN1 results in the release of PROTEIN , which is correlated temporally with the activation of PROTEIN2-mediated transcription .
1	265 , 21561-21566 ) we have shown that dimerization of PROTEIN1 was required for interaction with the cytoskeletal component PROTEIN2 .
0	The results of his3 activation indicated that PROTEIN1 , N + C-SH2 and C-SH2 interact with both PROTEIN2 beta and PROTEIN beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN beta .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-PROTEIN1 and PROTEIN2-FD8 .
0	PROTEIN prevents cyclinA/cdk2 containing PROTEIN1PROTEIN2 containing PROTEIN complexes formation in terminally differentiated myocytes .
1	This activation with PROTEIN1 and PROTEIN beta was 4-fold less as compared to PROTEIN2 and was somewhat increased ( 2-fold ) for PROTEIN beta ( delta C-43 ) .
1	PROTEIN1 is shown to interact with the largest subunit ( PROTEIN ) of human PROTEIN through its central region and with multiple activators -- including PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , adenoviral PROTEIN , and human immunodeficiency virus-type 1 PROTEIN proteins -- through a distinct amino-terminal domain .
0	Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN1 ( PROTEIN ) protein PROTEIN and the pocket proteins PROTEIN , PROTEIN and pRb2/PROTEIN2 .
0	An PROTEIN complex containing mainly PROTEIN and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/PROTEIN1PROTEIN2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN1 function , and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for PROTEIN2/Bcl-2 homodimerization .
0	PROTEIN also interacted with PROTEIN1 and PROTEIN and with the dominant inhibitors PROTEIN and Bcl-X-S. PROTEIN displayed the same pattern of combinatorial interactions with PROTEIN family proteins as PROTEIN2 .
0	Therefore , 1 ) the presence of GRs and PROTEIN in nasal polyps from nonallergic patients , as well as upregulation of PROTEIN1PROTEIN2 in nasal polyps from nonallergic patients , as well as upregulation of PROTEIN expression , suggests that inflammation may play an important role in the pathophysiology of nasal polyps ; and 2 ) glucocorticoid could be a potential treatment method for suppressing inflammatory processes .
0	Activation of lacZ upon interaction of PROTEIN with PROTEIN beta ( PROTEIN1PROTEIN2 with PROTEIN beta ( delta C-43 ) was 4-fold less as compared to PROTEIN beta .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	PROTEIN also interacted with PROTEIN1 and PROTEIN and with the dominant inhibitors PROTEIN2 and Bcl-X-S. PROTEIN displayed the same pattern of combinatorial interactions with PROTEIN family proteins as PROTEIN .
0	Regulation of the PROTEIN1-related transcription factor PROTEIN2 by binding to the PROTEIN protein .
0	An PROTEIN complex containing mainly PROTEIN and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN1PROTEIN2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	In differentiating C2C12 cells , PROTEIN complexes switch and DNA synthesis in response to serum are prevented when PROTEIN DNA binding activity and the cdks inhibitor PROTEIN downstream effector PROTEIN1PROTEIN2 downstream effector PROTEIN are induced .
1	Measurement of PROTEIN1 I3A , I5A interaction with the human thyroid AKAP , PROTEIN2 , by two independent methods suggests that mutation of isoleucines 3 and 5 decreases affinity by at least 6-fold .
0	An PROTEIN1 complex containing mainly PROTEIN and PROTEIN2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	Interaction of the PROTEIN subunit of PI 3-kinase with the PROTEIN1 receptor ( PROTEIN ) and the PROTEIN2 receptor ( PROTEIN ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
0	Withdrawal from the cell cycle of differentiating myocytes is regulated by the PROTEIN1 ( PROTEIN ) protein PROTEIN and the pocket proteins PROTEIN2 , PROTEIN and pRb2/p130 .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-PROTEIN1PROTEIN2-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	Use of deletion mutants of PROTEIN suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN1PROTEIN2 suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN protein , since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN amino acids 83-218 .
0	PROTEIN is highly similar to an identified murine PROTEIN1 both at the cDNA ( 82.8 % identity ) and the protein ( 77.4 % identity ) levels , and related to tumor necrosis factor/PROTEIN2 .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN1 , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-PROTEIN2 and Fas-FD8 .
1	Using PROTEIN as bait and supplying an exogenous tyrosine kinase gene to the yeast cells , we have found that PROTEIN1 interacts with another signaling protein , PROTEIN2 .
0	An PROTEIN complex containing mainly PROTEIN and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( PROTEIN1PROTEIN2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
1	PROTEIN1 is shown to interact with the largest subunit ( PROTEIN ) of human PROTEIN through its central region and with multiple activators -- including PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , adenoviral PROTEIN , and human immunodeficiency virus-type 1 PROTEIN proteins -- through a distinct amino-terminal domain .
1	Coassociation of PROTEIN1 ( dipeptidyl peptidase IV ) with PROTEIN2 on the surface of human T lymphocytes .
0	In the present study , we examined the presence of glucocorticoid receptors ( GRs ) and PROTEIN ( PROTEIN1PROTEIN2 ( PROTEIN ) in the nasal polyps of nonallergic patients as compared with normal controls .
0	The results of his3 activation indicated that PROTEIN , N + C-SH2 and C-SH2 interact with both PROTEIN beta and PROTEIN beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN1PROTEIN2 , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN beta .
0	In the present report , we demonstrated that modulation of PROTEIN from T cell surface induced by antiCD26 ( 1F7 ) led to enhanced phosphorylation of PROTEIN1PROTEIN2 ( 1F7 ) led to enhanced phosphorylation of PROTEIN zeta tyrosine residues and increased PROTEIN associated p56lck tyrosine kinase activity .
1	This activation with PROTEIN1 and PROTEIN beta was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN2 ( delta C-43 ) .
1	PROTEIN prevents PROTEIN1/PROTEIN2 containing PROTEIN complexes formation in terminally differentiated myocytes .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1PROTEIN2 , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( PROTEIN1-MyoD ) chimerae , we found that estrogen directed PROTEIN2 activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
1	Regulation of the Ets-related transcription factor PROTEIN1 by binding to the PROTEIN2 protein .
1	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN1 , which binds PROTEIN and PROTEIN2-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and Fas-FD8 .
0	This cytotoxicity could be abrogated by B42 fusion proteins containing PROTEIN , PROTEIN1PROTEIN2 , PROTEIN , or PROTEIN but not those containing PROTEIN ( an alternatively spliced form of PROTEIN that lacks a well-conserved 63-amino acid region ) .
0	The cloning of a complementary DNA encoding a human PROTEIN1 TAF , PROTEIN2 , that has no known homolog in Drosophila PROTEIN is now described .
0	An PROTEIN complex containing mainly PROTEIN1 and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the PROTEIN2/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
1	The present study has shown that cell surface PROTEIN1 binds to the PROTEIN2 mediating its mitogenic activity .
0	The structure provides evidence that the PROTEIN1-p53 complex forms in vivo and may have a critical role in the PROTEIN2 pathway of tumor suppression .
0	Using the cytoplasmic domain of PROTEIN1 in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and PROTEIN2-FD8 .
0	Interaction of PROTEIN and N+C-SH2 with PROTEIN beta ( delta C-43 ) or PROTEIN1PROTEIN2 ( delta C-43 ) or PROTEIN beta ( delta C-43 ) in which the C-terminal 43 amino acids ( including the YXXM motif ) were deleted , persisted .
0	Our data indicate that , in differentiating myocytes , one mechanism through which PROTEIN induces permanent cell cycle arrest involves PROTEIN upregulation and suppression of the proliferation-associated cdks-containing PROTEIN1PROTEIN2 induces permanent cell cycle arrest involves PROTEIN upregulation and suppression of the proliferation-associated cdks-containing PROTEIN complexes formation .
0	Whereas PROTEIN serves as an alternative accessory protein to the common cytokine receptor gamma chain ( PROTEIN ) for PROTEIN1 signaling , it could not replace the function of PROTEIN in allowing enhanced PROTEIN2 binding activity .
0	Use of deletion mutants of PROTEIN suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN protein , since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN1PROTEIN2 suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN protein , since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN amino acids 83-218 .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	PROTEIN is shown to interact with the largest subunit ( PROTEIN1 ) of human PROTEIN through its central region and with multiple activators -- including PROTEIN , PROTEIN , PROTEIN , PROTEIN , adenoviral PROTEIN2 , and human immunodeficiency virus-type 1 PROTEIN proteins -- through a distinct amino-terminal domain .
0	Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ( PROTEIN1 ) protein PROTEIN2 and the pocket proteins PROTEIN , PROTEIN and pRb2/p130 .
0	The putative activation domain of SREBP was shown to bind specifically to amino-terminal domains of recombinant PROTEIN1 and PROTEIN2 ( a CBP-related protein ) .
0	In contrast to LexA/Bcl-2 fusion proteins , expression of a LexA/PROTEIN1PROTEIN2 fusion proteins , expression of a LexA/Bax protein was lethal to yeast .
0	This activation with PROTEIN and PROTEIN beta was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN1PROTEIN2 and was somewhat increased ( 2-fold ) for PROTEIN beta ( delta C-43 ) .
0	PROTEIN1 also interacted with PROTEIN and PROTEIN and with the dominant inhibitors PROTEIN and Bcl-X-S. PROTEIN displayed the same pattern of combinatorial interactions with PROTEIN2 family proteins as PROTEIN .
0	The results of his3 activation indicated that PROTEIN , N + C-SH2 and C-SH2 interact with both PROTEIN beta and PROTEIN beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN1PROTEIN2 beta and PROTEIN beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN beta .
0	Overexpression of PROTEIN in MCF7 and BJAB cells induces apoptosis , which , like Fas-induced apoptosis , is blocked by PROTEIN1PROTEIN2 in MCF7 and BJAB cells induces apoptosis , which , like Fas-induced apoptosis , is blocked by PROTEIN , a specific inhibitor of the interleukin-1 beta-converting enzyme .
0	Use of deletion mutants of PROTEIN suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN protein , since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN1PROTEIN2 homodimerization involves interactions between two distinct regions within the PROTEIN protein , since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN amino acids 83-218 .
0	Interaction of the PROTEIN1 subunit of PI 3-kinase with the PROTEIN2 ( PROTEIN ) and the PROTEIN receptor ( PROTEIN ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
0	In contrast , in normal nasal tissues , PROTEIN1 labeling was only found in the vascular wall , and the expression was weaker -- a finding demonstrating that PROTEIN2 is upregulated in nasal polyps .
0	The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN function , and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/PROTEIN1PROTEIN2 and PROTEIN differentially regulate PROTEIN function , and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization .
0	The results of his3 activation indicated that PROTEIN , N + C-SH2 and C-SH2 interact with both PROTEIN beta and PROTEIN beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN1PROTEIN2 beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN beta .
0	PROTEIN contains a death domain homologous to the death domains of PROTEIN1 and PROTEIN2 .
0	Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ( PROTEIN1 ) protein PROTEIN and the pocket proteins PROTEIN , PROTEIN and pRb2/PROTEIN2 .
1	Co-immunoprecipitation experiments demonstrated an association between PROTEIN1 and PROTEIN2 in resting normal human T cells .
0	PROTEIN is shown to interact with the largest subunit ( PROTEIN1 ) of human PROTEIN through its central region and with multiple activators -- including PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , adenoviral PROTEIN , and human immunodeficiency virus-type 1 PROTEIN proteins -- through a distinct amino-terminal domain .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN1PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
1	Activation of lacZ upon interaction of PROTEIN1 with PROTEIN beta ( delta C-43 ) was 4-fold less as compared to PROTEIN2 .
0	PROTEIN1 also interacted with PROTEIN and PROTEIN and with the dominant inhibitors PROTEIN and Bcl-X-S. PROTEIN2 displayed the same pattern of combinatorial interactions with PROTEIN family proteins as PROTEIN .
0	This cytotoxicity could be abrogated by B42 fusion proteins containing PROTEIN , PROTEIN , or PROTEIN but not those containing PROTEIN1 ( an alternatively spliced form of PROTEIN2 that lacks a well-conserved 63-amino acid region ) .
0	The structure provides evidence that the 53BP2-PROTEIN1 complex forms in vivo and may have a critical role in the PROTEIN2 pathway of tumor suppression .
0	Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ( PROTEIN ) protein PROTEIN1 and the pocket proteins PROTEIN , PROTEIN and PROTEIN2/p130 .
0	PROTEIN1 contains a death domain homologous to the death domains of PROTEIN2 and PROTEIN .
0	Peptide sequencing and Western blot analysis established that the 265-kD protein was PROTEIN1 ( PROTEIN2 ) , a recently identified transcriptional coactivator .
1	PROTEIN1 also interacted with PROTEIN and PROTEIN and with the dominant inhibitors PROTEIN2 and Bcl-X-S. PROTEIN displayed the same pattern of combinatorial interactions with PROTEIN family proteins as PROTEIN .
0	An PROTEIN complex containing mainly PROTEIN and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( PROTEIN1PROTEIN2/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	Use of deletion mutants of PROTEIN suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN protein , since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN1PROTEIN2 homodimerization involves interactions between two distinct regions within the PROTEIN protein , since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN amino acids 83-218 .
0	PROTEIN1 prevents cyclinA/PROTEIN2 containing PROTEIN complexes formation in terminally differentiated myocytes .
0	Interactions of the PROTEIN protein with itself and other members of the PROTEIN family , including PROTEIN , PROTEIN , PROTEIN1PROTEIN2 , PROTEIN , and PROTEIN , were explored with a yeast two-hybrid system .
0	Whereas PROTEIN serves as an alternative accessory protein to the common PROTEIN1 ( PROTEIN ) for PROTEIN2 signaling , it could not replace the function of PROTEIN in allowing enhanced PROTEIN binding activity .
0	An PROTEIN complex containing mainly PROTEIN and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN1PROTEIN2/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	Whereas PROTEIN serves as an alternative accessory protein to the common PROTEIN1 ( PROTEIN ) for PROTEIN signaling , it could not replace the function of PROTEIN2 in allowing enhanced PROTEIN binding activity .
0	Overexpression of PROTEIN in MCF7 and BJAB cells induces apoptosis , which , like Fas-induced apoptosis , is blocked by PROTEIN , a specific inhibitor of the PROTEIN1PROTEIN2-induced apoptosis , is blocked by PROTEIN , a specific inhibitor of the interleukin-1 beta-converting enzyme .
0	Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ( PROTEIN ) protein PROTEIN and the pocket proteins PROTEIN1 , PROTEIN and PROTEIN2/p130 .
0	Interaction of PROTEIN and N+C-SH2 with PROTEIN beta ( delta C-43 ) or PROTEIN1PROTEIN2 beta ( delta C-43 ) in which the C-terminal 43 amino acids ( including the YXXM motif ) were deleted , persisted .
0	Activation of lacZ upon interaction of PROTEIN with PROTEIN beta ( delta C-43 ) was 4-fold less as compared to PROTEIN1PROTEIN2 ( delta C-43 ) was 4-fold less as compared to PROTEIN beta .
0	The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN function , and indicate that requirements for PROTEIN1/Bax heterodimerization may be different from those for PROTEIN2/Bcl-2 homodimerization .
0	This activation with PROTEIN and PROTEIN beta was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN1PROTEIN2 was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN beta ( delta C-43 ) .
1	PROTEIN1 also interacted with PROTEIN and PROTEIN2 and with the dominant inhibitors PROTEIN and Bcl-X-S. PROTEIN displayed the same pattern of combinatorial interactions with PROTEIN family proteins as PROTEIN .
1	Expressed in a murine myeloma , PROTEIN1 was identified as a ligand for PROTEIN2 by binding to a soluble PROTEIN construct .
0	This cytotoxicity could be abrogated by B42 fusion proteins containing PROTEIN , PROTEIN , or PROTEIN but not those containing PROTEIN1PROTEIN2 but not those containing PROTEIN ( an alternatively spliced form of PROTEIN that lacks a well-conserved 63-amino acid region ) .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-PROTEIN1 ) chimerae , we found that estrogen directed PROTEIN2 activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
1	An PROTEIN complex containing mainly PROTEIN1 and pRb2/PROTEIN2 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	Interaction of PROTEIN subunit of PI 3-kinase with PROTEIN1PROTEIN2 with PROTEIN and PROTEIN receptors analysed by using the two-hybrid system .
0	Interaction of the PROTEIN subunit of PI 3-kinase with the PROTEIN receptor ( PROTEIN1 ) and the PROTEIN2 ( PROTEIN ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
0	An PROTEIN complex containing mainly PROTEIN and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN1PROTEIN2 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
1	PROTEIN1 is shown to interact with the largest subunit ( PROTEIN ) of human PROTEIN through its central region and with multiple activators -- including PROTEIN , PROTEIN , PROTEIN , PROTEIN , adenoviral PROTEIN2 , and human immunodeficiency virus-type 1 PROTEIN proteins -- through a distinct amino-terminal domain .
0	An PROTEIN complex containing mainly PROTEIN and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( PROTEIN1PROTEIN2-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	Interactions of the PROTEIN protein with itself and other members of the PROTEIN family , including PROTEIN , PROTEIN , PROTEIN1PROTEIN2 family , including PROTEIN , PROTEIN , PROTEIN , and PROTEIN , were explored with a yeast two-hybrid system .
0	We further showed that PROTEIN was comodulated on the T cell surface with PROTEIN , a known membrane-linked protein tyrosine phosphatase and that anti-PROTEIN1 was capable of precipitating PROTEIN2 from T cell lysates .
1	Interactions of the PROTEIN1 protein with itself and other members of the PROTEIN family , including PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , were explored with a yeast two-hybrid system .
1	An PROTEIN complex containing mainly PROTEIN and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the PROTEIN1/PROTEIN2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	Interactions of the PROTEIN protein with itself and other members of the PROTEIN family , including PROTEIN , PROTEIN1PROTEIN2 family , including PROTEIN , PROTEIN , PROTEIN , and PROTEIN , were explored with a yeast two-hybrid system .
0	Interaction of the PROTEIN subunit of PI 3-kinase with the PROTEIN1 ( PROTEIN ) and the PROTEIN receptor ( PROTEIN2 ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN1PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	The crystal structure of the PROTEIN core domain bound to the PROTEIN1 protein , which contains an SH3 ( Src homology 3 ) domain and four ankyrin repeats , revealed that ( i ) the SH3 domain binds the L3 loop of PROTEIN in a manner distinct from that of previously characterized SH3-polyproline peptide complexes , and ( ii ) an ankyrin repeat , which forms an L-shaped structure consisting of a beta hairpin and two alpha helices , binds the L2 loop of PROTEIN2 .
0	The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN function , and indicate that requirements for PROTEIN1PROTEIN2 and PROTEIN differentially regulate PROTEIN function , and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization .
0	A point mutation in PROTEIN , analogous to the lpr mutation of PROTEIN1 , abolishes its ability to bind PROTEIN2 , suggesting a death domain to death domain interaction .
1	An PROTEIN complex containing mainly PROTEIN1 and PROTEIN2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
1	Use of the two hybrid system to detect the association of the protein-tyrosine-phosphatase , PROTEIN1 , with another SH2-containing protein , PROTEIN2 .
0	In the present report , we demonstrated that modulation of PROTEIN1 from T cell surface induced by antiPROTEIN2 ( 1F7 ) led to enhanced phosphorylation of PROTEIN zeta tyrosine residues and increased PROTEIN associated p56lck tyrosine kinase activity .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN1 , PROTEIN , PROTEIN2 , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
1	The structure provides evidence that the PROTEIN1-PROTEIN2 complex forms in vivo and may have a critical role in the PROTEIN pathway of tumor suppression .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1PROTEIN2 , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
1	The two residues of PROTEIN1 that contribute the majority of free energy for PROTEIN2 binding , Phe-156 and Lys-159 are surrounded by other residues which have only a moderate impact .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN1PROTEIN2 , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	An PROTEIN complex containing mainly PROTEIN and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN1PROTEIN2 and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-PROTEIN1PROTEIN2 ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants PROTEIN1-LPR and PROTEIN2-FD8 .
0	PROTEIN also interacted with PROTEIN and PROTEIN and with the dominant inhibitors PROTEIN1 and Bcl-X-S. PROTEIN displayed the same pattern of combinatorial interactions with PROTEIN2 family proteins as PROTEIN .
1	The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN function , and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for PROTEIN1/PROTEIN2 homodimerization .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and PROTEIN1-PROTEIN2 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and Fas-FD8 .
1	Whereas PROTEIN1 serves as an alternative accessory protein to the common cytokine receptor gamma chain ( PROTEIN ) for PROTEIN2 signaling , it could not replace the function of PROTEIN in allowing enhanced PROTEIN binding activity .
0	A point mutation in PROTEIN1 , analogous to the lpr mutation of PROTEIN2 , abolishes its ability to bind PROTEIN , suggesting a death domain to death domain interaction .
0	The internal binding site thus revealed was not altered by further mutating Y960/F for PROTEIN1 or Y950/F for PROTEIN2 .
0	PROTEIN is shown to interact with the largest subunit ( PROTEIN ) of human PROTEIN through its central region and with multiple activators -- including PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN , adenoviral PROTEIN , and human immunodeficiency virus-type 1 PROTEIN proteins -- through a distinct amino-terminal domain .
0	Interaction of the PROTEIN subunit of PI 3-kinase with the PROTEIN1PROTEIN2 subunit of PI 3-kinase with the PROTEIN receptor ( PROTEIN ) and the PROTEIN receptor ( PROTEIN ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
0	Whereas PROTEIN serves as an alternative accessory protein to the common cytokine receptor gamma chain ( PROTEIN ) for PROTEIN signaling , it could not replace the function of PROTEIN1 in allowing enhanced PROTEIN2 binding activity .
0	PROTEIN is shown to interact with the largest subunit ( PROTEIN ) of human PROTEIN through its central region and with multiple activators -- including PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , adenoviral PROTEIN , and human immunodeficiency virus-type 1 PROTEIN proteins -- through a distinct amino-terminal domain .
0	PROTEIN1 is a multisubunit protein complex comprised of the TATA-binding protein ( PROTEIN2 ) and multiple TBP-associated factors ( TAFs ) .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN1PROTEIN2-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	The results of his3 activation indicated that PROTEIN , N + C-SH2 and C-SH2 interact with both PROTEIN beta and PROTEIN beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN1PROTEIN2 , N + C-SH2 and C-SH2 interact with both PROTEIN beta and PROTEIN beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN beta .
1	Interaction of the PROTEIN subunit of PROTEIN1 with the PROTEIN2 ( PROTEIN ) and the PROTEIN receptor ( PROTEIN ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
0	Use of deletion mutants of PROTEIN suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN protein , since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN1PROTEIN2 suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN protein , since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN amino acids 83-218 .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN1 possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and Fas-PROTEIN2 .
0	This cytotoxicity could be abrogated by B42 fusion proteins containing PROTEIN1 , PROTEIN , or PROTEIN but not those containing PROTEIN ( an alternatively spliced form of PROTEIN2 that lacks a well-conserved 63-amino acid region ) .
0	These findings strongly suggest that PROTEIN1 may be closely associated with the PROTEIN protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of PROTEIN with PROTEIN2 results in enhanced tyrosine kinase activity , zeta chain phosphorylation , and T cell activation .
0	The PROTEIN1 gene product ( PROTEIN2 ) is a nuclear phosphoprotein that regulates cell cycle progression .
0	PROTEIN also interacted with PROTEIN and PROTEIN and with the dominant inhibitors PROTEIN1 and PROTEIN2 .
0	An PROTEIN complex containing mainly PROTEIN and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( PROTEIN1PROTEIN2 and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	A cDNA clone , designated PROTEIN ( PROTEIN1PROTEIN2 ( TNF-related activation protein ) was isolated from a collection of T cell activation genes .
0	An PROTEIN complex containing mainly PROTEIN and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN1PROTEIN2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	PROTEIN also interacted with PROTEIN and PROTEIN1 and with the dominant inhibitors PROTEIN and Bcl-X-S. PROTEIN displayed the same pattern of combinatorial interactions with PROTEIN family proteins as PROTEIN2 .
0	Interaction of the PROTEIN1 subunit of PI 3-kinase with the PROTEIN receptor ( PROTEIN ) and the PROTEIN2 receptor ( PROTEIN ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
1	Thus , PROTEIN1 encodes a human FGF receptor with high affinity for both PROTEIN2 and PROTEIN .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , PROTEIN1PROTEIN2 , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	PROTEIN is shown to interact with the largest subunit ( PROTEIN ) of human PROTEIN through its central region and with multiple activators -- including PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , adenoviral PROTEIN , and human immunodeficiency virus-type 1 PROTEIN proteins -- through a distinct amino-terminal domain .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/PROTEIN1PROTEIN2 ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	Whereas PROTEIN serves as an alternative accessory protein to the common cytokine receptor gamma chain ( PROTEIN ) for PROTEIN1 signaling , it could not replace the function of PROTEIN2 in allowing enhanced PROTEIN binding activity .
0	This cytotoxicity could be abrogated by B42 fusion proteins containing PROTEIN , PROTEIN , or PROTEIN but not those containing PROTEIN1PROTEIN2 , PROTEIN , or PROTEIN but not those containing PROTEIN ( an alternatively spliced form of PROTEIN that lacks a well-conserved 63-amino acid region ) .
0	The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN function , and indicate that requirements for PROTEIN1PROTEIN2 differentially regulate PROTEIN function , and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization .
0	PROTEIN binds exclusively to the underphosphorylated form of PROTEIN1 and fails to bind to PROTEIN2 mutants derived from patients with PROTEIN .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and PROTEIN1PROTEIN2 in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and Fas-FD8 .
1	Cloning of PROTEIN1 , a ligand for PROTEIN2 on human T cells .
0	SREBP transcriptional activity is mediated through an interaction with the PROTEIN1PROTEIN2 .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-PROTEIN1 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and Fas-PROTEIN2 .
0	PROTEIN is a multisubunit protein complex comprised of the PROTEIN1PROTEIN2 is a multisubunit protein complex comprised of the TATA-binding protein ( PROTEIN ) and multiple TBP-associated factors ( TAFs ) .
0	The crystal structure of the PROTEIN1 core domain bound to the PROTEIN protein , which contains an SH3 ( Src homology 3 ) domain and four ankyrin repeats , revealed that ( i ) the SH3 domain binds the L3 loop of PROTEIN in a manner distinct from that of previously characterized SH3-polyproline peptide complexes , and ( ii ) an ankyrin repeat , which forms an L-shaped structure consisting of a beta hairpin and two alpha helices , binds the L2 loop of PROTEIN2 .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , PROTEIN1PROTEIN2 , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	PROTEIN also interacted with PROTEIN and PROTEIN and with the dominant inhibitors PROTEIN1 and Bcl-X-S. PROTEIN displayed the same pattern of combinatorial interactions with PROTEIN family proteins as PROTEIN2 .
0	Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ( PROTEIN ) protein PROTEIN and the pocket proteins PROTEIN , PROTEIN and PROTEIN1/PROTEIN2 .
1	Thus , the C-terminal domain in PROTEIN1 appears to exert a negative control on binding of PROTEIN2 thereby providing a possible regulatory mechanism for direct activation of the PI 3-kinase pathway .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/PROTEIN1 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN2 activity and the inability of cells to re-enter the cell cycle .
1	The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN function , and indicate that requirements for PROTEIN1/PROTEIN2 heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization .
0	PROTEIN is shown to interact with the largest subunit ( PROTEIN ) of human PROTEIN1 through its central region and with multiple activators -- including PROTEIN , PROTEIN , PROTEIN , PROTEIN , adenoviral PROTEIN , and human immunodeficiency virus-type 1 PROTEIN2 proteins -- through a distinct amino-terminal domain .
0	The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN function , and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for PROTEIN1PROTEIN2 differentially regulate PROTEIN function , and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization .
0	The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN1PROTEIN2 and PROTEIN differentially regulate PROTEIN function , and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization .
1	The core domain contains the sequence-specific DNA binding activity and the in vitro PROTEIN1 protein binding activity of PROTEIN2 .
0	The cloning of a complementary DNA encoding a human PROTEIN1 TAF , PROTEIN , that has no known homolog in Drosophila PROTEIN2 is now described .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN1PROTEIN2 , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN1PROTEIN2 activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
1	A point mutation in PROTEIN1 , analogous to the lpr mutation of PROTEIN , abolishes its ability to bind PROTEIN2 , suggesting a death domain to death domain interaction .
1	Interaction of the PROTEIN subunit of PROTEIN1 with the PROTEIN receptor ( PROTEIN2 ) and the PROTEIN receptor ( PROTEIN ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
0	This activation with PROTEIN and PROTEIN beta was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN beta ( PROTEIN1PROTEIN2 ( delta C-43 ) .
0	Whereas PROTEIN serves as an alternative accessory protein to the common cytokine receptor gamma chain ( PROTEIN1 ) for PROTEIN2 signaling , it could not replace the function of PROTEIN in allowing enhanced PROTEIN binding activity .
0	Use of deletion mutants of PROTEIN suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN protein , since a LexA protein containing PROTEIN1PROTEIN2 homodimerization involves interactions between two distinct regions within the PROTEIN protein , since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN amino acids 83-218 .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN1 possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and PROTEIN2-FD8 .
0	The results of his3 activation indicated that PROTEIN , N + C-SH2 and C-SH2 interact with both PROTEIN1 beta and PROTEIN2 beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN beta .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1PROTEIN2 , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN function , and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/PROTEIN1PROTEIN2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1PROTEIN2 , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
1	Abolition of the PROTEIN1 binding site in PROTEIN2 created antagonists of LIF action .
0	Interactions of the PROTEIN protein with itself and other members of the PROTEIN family , including PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN2 , were explored with a yeast two-hybrid system .
0	An PROTEIN complex containing mainly PROTEIN and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( PROTEIN1PROTEIN2 complex containing mainly PROTEIN and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	Use of deletion mutants of PROTEIN suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN1PROTEIN2 homodimerization involves interactions between two distinct regions within the PROTEIN protein , since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN amino acids 83-218 .
0	The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN function , and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/PROTEIN1PROTEIN2 function , and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization .
0	PROTEIN is shown to interact with the largest subunit ( PROTEIN ) of human PROTEIN1 through its central region and with multiple activators -- including PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , adenoviral PROTEIN , and human immunodeficiency virus-type 1 PROTEIN proteins -- through a distinct amino-terminal domain .
0	Overexpression of PROTEIN in MCF7 and BJAB cells induces apoptosis , which , like Fas-induced apoptosis , is blocked by PROTEIN , a specific inhibitor of the PROTEIN1PROTEIN2-converting enzyme .
0	This activation with PROTEIN and PROTEIN1PROTEIN2 and PROTEIN beta was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN beta ( delta C-43 ) .
0	Nevertheless , the overall size and length of the cytoplasmic domain of PROTEIN and PROTEIN are similar , and like PROTEIN , PROTEIN1PROTEIN2 , PROTEIN is located on chromosome X .
0	Interaction of PROTEIN and N+C-SH2 with PROTEIN beta ( delta C-43 ) or PROTEIN1PROTEIN2 and N+C-SH2 with PROTEIN beta ( delta C-43 ) or PROTEIN beta ( delta C-43 ) in which the C-terminal 43 amino acids ( including the YXXM motif ) were deleted , persisted .
1	PROTEIN1 also interacted with PROTEIN and PROTEIN and with the dominant inhibitors PROTEIN and PROTEIN2 .
0	Interaction of the PROTEIN subunit of PROTEIN1 with the PROTEIN receptor ( PROTEIN ) and the PROTEIN2 receptor ( PROTEIN ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
0	Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ( PROTEIN ) protein PROTEIN1 and the pocket proteins PROTEIN2 , PROTEIN and pRb2/p130 .
0	PROTEIN1 prevents PROTEIN2/cdk2 containing PROTEIN complexes formation in terminally differentiated myocytes .
0	Nevertheless , the overall size and length of the cytoplasmic domain of PROTEIN and PROTEIN are similar , and like PROTEIN , PROTEIN1PROTEIN2 and PROTEIN are similar , and like PROTEIN , PROTEIN is located on chromosome X .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN2 ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN1PROTEIN2 in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and Fas-FD8 .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants PROTEIN1-PROTEIN2 and Fas-FD8 .
0	Interaction of the PROTEIN subunit of PI 3-kinase with the PROTEIN1 ( PROTEIN ) and the PROTEIN2 receptor ( PROTEIN ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN1 and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants PROTEIN2-LPR and Fas-FD8 .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1PROTEIN2 , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	This activation with PROTEIN and PROTEIN beta was 4-fold less as compared to PROTEIN1PROTEIN2 was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN beta ( delta C-43 ) .
0	An PROTEIN complex containing mainly PROTEIN and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( PROTEIN1PROTEIN2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1PROTEIN2 , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	Activation of lacZ upon interaction of PROTEIN with PROTEIN beta ( PROTEIN1PROTEIN2 ( delta C-43 ) was 4-fold less as compared to PROTEIN beta .
0	Use of deletion mutants of PROTEIN suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN protein , since a LexA protein containing PROTEIN1PROTEIN2 suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN protein , since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN amino acids 83-218 .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and PROTEIN1-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and PROTEIN2-FD8 .
0	Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ( PROTEIN ) protein PROTEIN and the pocket proteins PROTEIN1 , PROTEIN2 and pRb2/p130 .
1	Activation of PROTEIN1 results in rapid , site-specific dephosphorylation of PROTEIN2 at one or more of these three sites and is coincident with increased AP-1-binding activity .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( PROTEIN1 , PROTEIN2 , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	Interaction of the PROTEIN subunit of PI 3-kinase with the PROTEIN1 receptor ( PROTEIN2 ) and the PROTEIN receptor ( PROTEIN ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
1	The carboxy-terminal region of PROTEIN1 has previously been shown to interact directly with PROTEIN2 , a cytoplasmic component of the dystrophin-glycoprotein complex , by in vitro biochemical studies such as overlay assay or immunoprecipitation .
0	The results of his3 activation indicated that PROTEIN , N + C-SH2 and C-SH2 interact with both PROTEIN beta and PROTEIN beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN1PROTEIN2 and PROTEIN beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN beta .
0	An PROTEIN complex containing mainly PROTEIN and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/PROTEIN1PROTEIN2 complex containing mainly PROTEIN and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( PROTEIN1PROTEIN2 ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	An PROTEIN complex containing mainly PROTEIN and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN1PROTEIN2 complex containing mainly PROTEIN and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	The putative activation domain of SREBP was shown to bind specifically to amino-terminal domains of recombinant PROTEIN and PROTEIN ( a PROTEIN1PROTEIN2 and PROTEIN ( a CBP-related protein ) .
0	Interaction of PROTEIN1 subunit of PROTEIN2 with PROTEIN and PROTEIN receptors analysed by using the two-hybrid system .
0	An PROTEIN complex containing mainly PROTEIN and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN1PROTEIN2-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	Interaction of the PROTEIN1 subunit of PI 3-kinase with the PROTEIN receptor ( PROTEIN2 ) and the PROTEIN receptor ( PROTEIN ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN1PROTEIN2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	PROTEIN also interacted with PROTEIN1 and PROTEIN and with the dominant inhibitors PROTEIN and Bcl-X-S. PROTEIN2 displayed the same pattern of combinatorial interactions with PROTEIN family proteins as PROTEIN .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN1PROTEIN2 activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	In this report , it is demonstrated that PROTEIN contains a sequence motif that is highly related to the PROTEIN binding sites of several viral oncoproteins and binds to the pocket region of PROTEIN1PROTEIN2 binding sites of several viral oncoproteins and binds to the pocket region of PROTEIN both in vitro and in vivo .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
1	The results of his3 activation indicated that PROTEIN1 , N + C-SH2 and C-SH2 interact with both PROTEIN2 and PROTEIN beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN beta .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/PROTEIN1PROTEIN2 ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
1	Residues in human PROTEIN1 ( PROTEIN ) crucial for binding to both the human LIF receptor ( R ) and PROTEIN2 were identified by analysis of alanine scanning mutants of PROTEIN in assays for both receptor binding and bioactivity .
0	An PROTEIN complex containing mainly PROTEIN and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/PROTEIN1PROTEIN2-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	The results of his3 activation indicated that PROTEIN , N + C-SH2 and C-SH2 interact with both PROTEIN1PROTEIN2 and PROTEIN beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN beta .
0	An PROTEIN complex containing mainly PROTEIN and pRb2/PROTEIN1 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the PROTEIN2/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN1PROTEIN2 , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	These findings strongly suggest that PROTEIN may be closely associated with the PROTEIN1 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of PROTEIN2 with PROTEIN results in enhanced tyrosine kinase activity , zeta chain phosphorylation , and T cell activation .
0	Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ( PROTEIN ) protein PROTEIN and the pocket proteins PROTEIN1 , PROTEIN and pRb2/PROTEIN2 .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN1 , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and Fas-PROTEIN2 .
0	PROTEIN is shown to interact with the largest subunit ( PROTEIN ) of human PROTEIN1 through its central region and with multiple activators -- including PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , adenoviral PROTEIN , and human immunodeficiency virus-type 1 PROTEIN proteins -- through a distinct amino-terminal domain .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN1PROTEIN2 , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
1	The mitogenic effects of the PROTEIN1 are mediated through cell surface PROTEIN2 .
0	Interaction of the PROTEIN1 subunit of PI 3-kinase with the PROTEIN receptor ( PROTEIN ) and the PROTEIN2 ( PROTEIN ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
0	Interaction of PROTEIN subunit of PI 3-kinase with PROTEIN and PROTEIN1PROTEIN2 subunit of PI 3-kinase with PROTEIN and PROTEIN receptors analysed by using the two-hybrid system .
0	Interaction of the PROTEIN subunit of PI 3-kinase with the PROTEIN1 receptor ( PROTEIN ) and the PROTEIN receptor ( PROTEIN2 ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
1	Measurement of PROTEIN1 I3A , I5A interaction with the human PROTEIN2 , Ht 31 , by two independent methods suggests that mutation of isoleucines 3 and 5 decreases affinity by at least 6-fold .
0	This activation with PROTEIN and PROTEIN beta was 4-fold less as compared to PROTEIN1PROTEIN2 beta was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN beta ( delta C-43 ) .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN1PROTEIN2 , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	PROTEIN1 also interacted with PROTEIN and PROTEIN and with the dominant inhibitors PROTEIN and Bcl-X-S. PROTEIN displayed the same pattern of combinatorial interactions with PROTEIN family proteins as PROTEIN2 .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN1PROTEIN2 , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-PROTEIN1 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants PROTEIN2-LPR and Fas-FD8 .
0	PROTEIN also interacted with PROTEIN and PROTEIN1 and with the dominant inhibitors PROTEIN2 and Bcl-X-S. PROTEIN displayed the same pattern of combinatorial interactions with PROTEIN family proteins as PROTEIN .
1	In resting human epithelial and fibroblastic cells , PROTEIN1 is phosphorylated on serine and threonine at five sites , three of which are phosphorylated in vitro by PROTEIN2 ( PROTEIN ) .
0	Whereas PROTEIN serves as an alternative accessory protein to the common cytokine receptor gamma chain ( PROTEIN1 ) for PROTEIN signaling , it could not replace the function of PROTEIN in allowing enhanced PROTEIN2 binding activity .
0	We further showed that PROTEIN was comodulated on the T cell surface with PROTEIN , a known membrane-linked protein tyrosine phosphatase and that anti-CD26 was capable of precipitating PROTEIN1PROTEIN2 was comodulated on the T cell surface with PROTEIN , a known membrane-linked protein tyrosine phosphatase and that anti-CD26 was capable of precipitating PROTEIN from T cell lysates .
1	Thus , during myogenic differentiation , formation of PROTEIN1 and PROTEIN2/p130 containing complexes is an early event , but not enough on its own to prevent the reactivation of DNA synthesis .
0	PROTEIN also interacted with PROTEIN and PROTEIN and with the dominant inhibitors PROTEIN and Bcl-X-S. PROTEIN displayed the same pattern of combinatorial interactions with PROTEIN1 family proteins as PROTEIN2 .
0	Using the cytoplasmic domain of PROTEIN1 in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-PROTEIN2 and Fas-FD8 .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-PROTEIN1 and Fas-PROTEIN2 .
1	Residues in human PROTEIN1 ( PROTEIN ) crucial for binding to both the human PROTEIN2 ( R ) and PROTEIN were identified by analysis of alanine scanning mutants of PROTEIN in assays for both receptor binding and bioactivity .
0	Interaction of the PROTEIN subunit of PI 3-kinase with the PROTEIN receptor ( PROTEIN1 ) and the PROTEIN2 receptor ( PROTEIN ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
0	An PROTEIN complex containing mainly PROTEIN and pRb2/p130 ( PROTEIN1-G0/G1 complex ) appears when DNA synthesis arrests , replacing the PROTEIN2/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	An PROTEIN complex containing mainly PROTEIN and pRb2/p130 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( PROTEIN1PROTEIN2 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ( PROTEIN1 ) protein PROTEIN and the pocket proteins PROTEIN2 , PROTEIN and pRb2/p130 .
1	Cloning and functional analysis of PROTEIN1 : a novel PROTEIN2-binding protein with anti-cell death activity .
0	This cytotoxicity could be abrogated by B42 fusion proteins containing PROTEIN , PROTEIN , or PROTEIN1 but not those containing PROTEIN ( an alternatively spliced form of PROTEIN2 that lacks a well-conserved 63-amino acid region ) .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/PROTEIN1PROTEIN2-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	An PROTEIN1 complex containing mainly PROTEIN and pRb2/PROTEIN2 ( E2F-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
1	PROTEIN1 also interacted with PROTEIN2 and PROTEIN and with the dominant inhibitors PROTEIN and Bcl-X-S. PROTEIN displayed the same pattern of combinatorial interactions with PROTEIN family proteins as PROTEIN .
1	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN1 , which binds PROTEIN and Fas-PROTEIN2 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and Fas-FD8 .
0	In the present report , we demonstrated that modulation of PROTEIN from T cell surface induced by antiCD26 ( 1F7 ) led to enhanced phosphorylation of PROTEIN zeta tyrosine residues and increased PROTEIN1PROTEIN2 from T cell surface induced by antiCD26 ( 1F7 ) led to enhanced phosphorylation of PROTEIN zeta tyrosine residues and increased PROTEIN associated p56lck tyrosine kinase activity .
0	PROTEIN is a multisubunit protein complex comprised of the PROTEIN1 ( PROTEIN2 ) and multiple TBP-associated factors ( TAFs ) .
0	PROTEIN is highly similar to an identified murine PROTEIN1PROTEIN2 is highly similar to an identified murine PROTEIN ligand both at the cDNA ( 82.8 % identity ) and the protein ( 77.4 % identity ) levels , and related to tumor necrosis factor/lymphotoxin .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	Nevertheless , the overall size and length of the cytoplasmic domain of PROTEIN and PROTEIN1PROTEIN2 and PROTEIN are similar , and like PROTEIN , PROTEIN is located on chromosome X .
0	The crystal structure of the PROTEIN core domain bound to the PROTEIN1 protein , which contains an SH3 ( Src homology 3 ) domain and four ankyrin repeats , revealed that ( i ) the SH3 domain binds the L3 loop of PROTEIN2 in a manner distinct from that of previously characterized SH3-polyproline peptide complexes , and ( ii ) an ankyrin repeat , which forms an L-shaped structure consisting of a beta hairpin and two alpha helices , binds the L2 loop of PROTEIN .
0	Use of deletion mutants of PROTEIN suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN protein , since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN1PROTEIN2 amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN amino acids 83-218 .
0	This activation with PROTEIN and PROTEIN beta was 4-fold less as compared to PROTEIN1 and was somewhat increased ( 2-fold ) for PROTEIN2 beta ( delta C-43 ) .
1	PROTEIN1 is shown to interact with the largest subunit ( PROTEIN ) of human PROTEIN through its central region and with multiple activators -- including PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , adenoviral PROTEIN , and human immunodeficiency virus-type 1 PROTEIN proteins -- through a distinct amino-terminal domain .
0	Nevertheless , the overall size and length of the cytoplasmic domain of PROTEIN and PROTEIN are similar , and like PROTEIN , PROTEIN1PROTEIN2 are similar , and like PROTEIN , PROTEIN is located on chromosome X .
0	The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN function , and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for PROTEIN1PROTEIN2 and PROTEIN differentially regulate PROTEIN function , and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization .
0	The experiments were performed with the cytoplasmic beta domain ( wild type or mutated ) of PROTEIN1 and PROTEIN and PROTEIN2 or its subdomains ( N + C-SH2 , N-SH2 , C-SH2 , SH3 + N-SH2 ) .
0	In this report , it is demonstrated that PROTEIN1 contains a sequence motif that is highly related to the PROTEIN2 binding sites of several viral oncoproteins and binds to the pocket region of PROTEIN both in vitro and in vivo .
0	The experiments were performed with the cytoplasmic beta domain ( wild type or mutated ) of PROTEIN and PROTEIN1 and PROTEIN2 or its subdomains ( N + C-SH2 , N-SH2 , C-SH2 , SH3 + N-SH2 ) .
0	The findings suggest a model whereby PROTEIN and PROTEIN1PROTEIN2 and PROTEIN differentially regulate PROTEIN function , and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization .
0	Interaction of the PROTEIN subunit of PI 3-kinase with the PROTEIN receptor ( PROTEIN1 ) and the PROTEIN receptor ( PROTEIN2 ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
0	Use of deletion mutants of PROTEIN suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN protein , since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN1PROTEIN2 protein , since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN amino acids 83-218 .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN1PROTEIN2-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	In an unbiased search for potential coactivators of SREBP , we isolated a protein of 265 kD from HeLa cells that directly bound PROTEIN1 and PROTEIN2 .
0	Interaction of the PROTEIN subunit of PI 3-kinase with the PROTEIN1 ( PROTEIN ) and the PROTEIN2 ( PROTEIN ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
0	This activation with PROTEIN and PROTEIN beta was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN1PROTEIN2 beta was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN beta ( delta C-43 ) .
0	This activation with PROTEIN and PROTEIN beta was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN1PROTEIN2 beta ( delta C-43 ) .
0	PROTEIN also interacted with PROTEIN and PROTEIN and with the dominant inhibitors PROTEIN1 and Bcl-X-S. PROTEIN2 displayed the same pattern of combinatorial interactions with PROTEIN family proteins as PROTEIN .
1	Only weak PROTEIN1 binding activity was found in cells transfected with only PROTEIN2 ; however , the combination of both PROTEIN and IL-4Ralpha resulted in substantial binding activity , with a Kd of approximately 400 pM , indicating that both chains are essential components of the PROTEIN receptor .
0	PROTEIN also interacted with PROTEIN1 and PROTEIN and with the dominant inhibitors PROTEIN and Bcl-X-S. PROTEIN displayed the same pattern of combinatorial interactions with PROTEIN2 family proteins as PROTEIN .
0	Interaction of PROTEIN and N+C-SH2 with PROTEIN beta ( delta C-43 ) or PROTEIN1PROTEIN2 ) or PROTEIN beta ( delta C-43 ) in which the C-terminal 43 amino acids ( including the YXXM motif ) were deleted , persisted .
0	We further showed that PROTEIN was comodulated on the T cell surface with PROTEIN , a known membrane-linked protein tyrosine phosphatase and that anti-PROTEIN1PROTEIN2 , a known membrane-linked protein tyrosine phosphatase and that anti-CD26 was capable of precipitating PROTEIN from T cell lysates .
0	These findings strongly suggest that PROTEIN may be closely associated with the PROTEIN1 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of PROTEIN with PROTEIN2 results in enhanced tyrosine kinase activity , zeta chain phosphorylation , and T cell activation .
0	Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ( PROTEIN1 ) protein PROTEIN and the pocket proteins PROTEIN , PROTEIN2 and pRb2/p130 .
1	Residues in PROTEIN1 from both the A- and C-helices are involved in binding the PROTEIN2 co-receptor .
0	Overexpression of PROTEIN in MCF7 and BJAB cells induces apoptosis , which , like Fas-induced apoptosis , is blocked by PROTEIN1PROTEIN2-induced apoptosis , is blocked by PROTEIN , a specific inhibitor of the interleukin-1 beta-converting enzyme .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and PROTEIN1-PROTEIN2 .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants PROTEIN1-LPR and Fas-PROTEIN2 .
0	This activation with PROTEIN and PROTEIN beta was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN beta ( PROTEIN1PROTEIN2 was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN beta ( delta C-43 ) .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN1 and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and Fas-PROTEIN2 .
0	Interaction of PROTEIN and N+C-SH2 with PROTEIN beta ( delta C-43 ) or PROTEIN beta ( PROTEIN1PROTEIN2 ) or PROTEIN beta ( delta C-43 ) in which the C-terminal 43 amino acids ( including the YXXM motif ) were deleted , persisted .
0	We further showed that PROTEIN was comodulated on the T cell surface with PROTEIN , a known membrane-linked protein tyrosine phosphatase and that anti-PROTEIN1PROTEIN2 was comodulated on the T cell surface with PROTEIN , a known membrane-linked protein tyrosine phosphatase and that anti-CD26 was capable of precipitating PROTEIN from T cell lysates .
0	Thus , during myogenic differentiation , formation of PROTEIN and PROTEIN1/PROTEIN2 containing complexes is an early event , but not enough on its own to prevent the reactivation of DNA synthesis .
0	PROTEIN is shown to interact with the largest subunit ( PROTEIN1 ) of human PROTEIN through its central region and with multiple activators -- including PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , adenoviral PROTEIN , and human immunodeficiency virus-type 1 PROTEIN proteins -- through a distinct amino-terminal domain .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN1 , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN2 possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and Fas-FD8 .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN1PROTEIN2-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	In the present report , we demonstrated that modulation of PROTEIN from T cell surface induced by antiCD26 ( 1F7 ) led to enhanced phosphorylation of PROTEIN1PROTEIN2 from T cell surface induced by antiCD26 ( 1F7 ) led to enhanced phosphorylation of PROTEIN zeta tyrosine residues and increased PROTEIN associated p56lck tyrosine kinase activity .
0	These findings suggest that PROTEIN may play an important role in the proximal signal transduction of PROTEIN1PROTEIN2 may play an important role in the proximal signal transduction of PROTEIN .
0	Expressed in a murine myeloma , PROTEIN was identified as a ligand for PROTEIN by binding to a soluble PROTEIN1PROTEIN2 by binding to a soluble PROTEIN construct .
1	We propose that PROTEIN1 is present in resting cells in a latent , phosphorylated form that can be activated by site-specific dephosphorylation in response to PROTEIN2 activation .
0	In differentiating C2C12 cells , PROTEIN complexes switch and DNA synthesis in response to serum are prevented when PROTEIN1PROTEIN2 complexes switch and DNA synthesis in response to serum are prevented when PROTEIN DNA binding activity and the cdks inhibitor PROTEIN downstream effector PROTEIN are induced .
0	PROTEIN1 binds exclusively to the underphosphorylated form of PROTEIN2 and fails to bind to PROTEIN mutants derived from patients with PROTEIN .
0	Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ( PROTEIN ) protein PROTEIN and the pocket proteins PROTEIN , PROTEIN1 and pRb2/PROTEIN2 .
0	PROTEIN is shown to interact with the largest subunit ( PROTEIN ) of human PROTEIN1 through its central region and with multiple activators -- including PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , adenoviral PROTEIN , and human immunodeficiency virus-type 1 PROTEIN proteins -- through a distinct amino-terminal domain .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and PROTEIN1-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-PROTEIN2 and Fas-FD8 .
0	Overexpression of PROTEIN in MCF7 and BJAB cells induces apoptosis , which , like Fas-induced apoptosis , is blocked by PROTEIN , a specific inhibitor of the PROTEIN1PROTEIN2 , a specific inhibitor of the interleukin-1 beta-converting enzyme .
1	We demonstrate that PROTEIN1 binds to PROTEIN2 in vitro under conditions where the latter is tyrosine-phosphorylated .
0	The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN1PROTEIN2 differentially regulate PROTEIN function , and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and PROTEIN1-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and Fas-PROTEIN2 .
0	Interactions of the PROTEIN protein with itself and other members of the PROTEIN family , including PROTEIN1PROTEIN2 family , including PROTEIN , PROTEIN , PROTEIN , and PROTEIN , were explored with a yeast two-hybrid system .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
1	Only the activated and not the latent forms of wild-type and C-terminal mutant des- ( 248-450 ) -PROTEIN1 proteins are able to form complexes with PROTEIN2 .
0	Nevertheless , the overall size and length of the cytoplasmic domain of PROTEIN and PROTEIN are similar , and like PROTEIN1PROTEIN2 and PROTEIN are similar , and like PROTEIN , PROTEIN is located on chromosome X .
1	Interaction of PROTEIN1 and N+C-SH2 with PROTEIN2 ( delta C-43 ) or PROTEIN beta ( delta C-43 ) in which the C-terminal 43 amino acids ( including the YXXM motif ) were deleted , persisted .
1	These findings strongly suggest that PROTEIN may be closely associated with the PROTEIN protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of PROTEIN1 with PROTEIN2 results in enhanced tyrosine kinase activity , zeta chain phosphorylation , and T cell activation .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN1PROTEIN2 ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	Whereas PROTEIN serves as an alternative accessory protein to the common PROTEIN1 ( PROTEIN2 ) for PROTEIN signaling , it could not replace the function of PROTEIN in allowing enhanced PROTEIN binding activity .
0	This activation with PROTEIN and PROTEIN1 was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN2 beta ( delta C-43 ) .
0	Interaction of PROTEIN and N+C-SH2 with PROTEIN beta ( delta C-43 ) or PROTEIN1PROTEIN2 ) or PROTEIN beta ( delta C-43 ) in which the C-terminal 43 amino acids ( including the YXXM motif ) were deleted , persisted .
0	In differentiating C2C12 cells , PROTEIN complexes switch and DNA synthesis in response to serum are prevented when PROTEIN DNA binding activity and the cdks inhibitor PROTEIN downstream effector PROTEIN1PROTEIN2 complexes switch and DNA synthesis in response to serum are prevented when PROTEIN DNA binding activity and the cdks inhibitor PROTEIN downstream effector PROTEIN are induced .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN1PROTEIN2 ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	Measurement of RII alpha I3A , I5A interaction with the human PROTEIN1 , PROTEIN2 , by two independent methods suggests that mutation of isoleucines 3 and 5 decreases affinity by at least 6-fold .
0	PROTEIN also interacted with PROTEIN and PROTEIN and with the dominant inhibitors PROTEIN and Bcl-X-S. PROTEIN1 displayed the same pattern of combinatorial interactions with PROTEIN family proteins as PROTEIN2 .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( PROTEIN1-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN2/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	These findings strongly suggest that PROTEIN1 may be closely associated with the PROTEIN2 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of PROTEIN with PROTEIN results in enhanced tyrosine kinase activity , zeta chain phosphorylation , and T cell activation .
0	PROTEIN prevents cyclinA/cdk2 containing PROTEIN1PROTEIN2 prevents cyclinA/cdk2 containing PROTEIN complexes formation in terminally differentiated myocytes .
0	The results of his3 activation indicated that PROTEIN , N + C-SH2 and C-SH2 interact with both PROTEIN beta and PROTEIN1PROTEIN2 beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN beta .
0	Interaction of PROTEIN and N+C-SH2 with PROTEIN beta ( delta C-43 ) or PROTEIN beta ( PROTEIN1PROTEIN2 beta ( delta C-43 ) in which the C-terminal 43 amino acids ( including the YXXM motif ) were deleted , persisted .
0	Interactions of the PROTEIN protein with itself and other members of the PROTEIN family , including PROTEIN , PROTEIN , PROTEIN , and PROTEIN1PROTEIN2 , PROTEIN , and PROTEIN , were explored with a yeast two-hybrid system .
0	Use of deletion mutants of PROTEIN suggested that PROTEIN homodimerization involves interactions between two distinct regions within the PROTEIN protein , since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN1PROTEIN2 protein , since a LexA protein containing PROTEIN amino acids 83-218 mediated functional interactions with a B42 fusion protein containing PROTEIN amino acids 1-81 but did not complement a B42 fusion protein containing PROTEIN amino acids 83-218 .
0	Whereas PROTEIN1 serves as an alternative accessory protein to the common cytokine receptor gamma chain ( PROTEIN ) for PROTEIN signaling , it could not replace the function of PROTEIN in allowing enhanced PROTEIN2 binding activity .
0	This activation with PROTEIN and PROTEIN beta was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN beta ( PROTEIN1PROTEIN2 beta was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN beta ( delta C-43 ) .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN1PROTEIN2 in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and Fas-FD8 .
0	Our data indicate that , in differentiating myocytes , one mechanism through which PROTEIN induces permanent cell cycle arrest involves PROTEIN upregulation and suppression of the proliferation-associated cdks-containing PROTEIN1PROTEIN2 upregulation and suppression of the proliferation-associated cdks-containing PROTEIN complexes formation .
0	Interaction of the PROTEIN subunit of PI 3-kinase with the PROTEIN1 receptor ( PROTEIN ) and the PROTEIN2 ( PROTEIN ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
0	In differentiating C2C12 cells , PROTEIN complexes switch and DNA synthesis in response to serum are prevented when PROTEIN DNA binding activity and the cdks inhibitor PROTEIN downstream effector PROTEIN1PROTEIN2 DNA binding activity and the cdks inhibitor PROTEIN downstream effector PROTEIN are induced .
0	This cytotoxicity could be abrogated by B42 fusion proteins containing PROTEIN , PROTEIN , or PROTEIN1PROTEIN2 , PROTEIN , or PROTEIN but not those containing PROTEIN ( an alternatively spliced form of PROTEIN that lacks a well-conserved 63-amino acid region ) .
0	In differentiating C2C12 cells , PROTEIN complexes switch and DNA synthesis in response to serum are prevented when PROTEIN DNA binding activity and the cdks inhibitor PROTEIN1PROTEIN2 complexes switch and DNA synthesis in response to serum are prevented when PROTEIN DNA binding activity and the cdks inhibitor PROTEIN downstream effector PROTEIN are induced .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-PROTEIN1PROTEIN2 in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and Fas-FD8 .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN1 and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-PROTEIN2 and Fas-FD8 .
0	Interactions of the PROTEIN protein with itself and other members of the PROTEIN1PROTEIN2 protein with itself and other members of the PROTEIN family , including PROTEIN , PROTEIN , PROTEIN , and PROTEIN , were explored with a yeast two-hybrid system .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN1PROTEIN2 in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and Fas-FD8 .
1	Here we report the crystal structure of the PROTEIN1 ectodomain in a dimeric form that is induced by simultaneous binding to PROTEIN2 and a heparin decasaccharide .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/PROTEIN1PROTEIN2 activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-PROTEIN1 , a mutant of PROTEIN2 possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and Fas-FD8 .
0	The experiments were performed with the cytoplasmic beta domain ( wild type or mutated ) of PROTEIN1 and PROTEIN2 and PROTEIN or its subdomains ( N + C-SH2 , N-SH2 , C-SH2 , SH3 + N-SH2 ) .
0	The results of his3 activation indicated that PROTEIN , N + C-SH2 and C-SH2 interact with both PROTEIN beta and PROTEIN beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN1PROTEIN2 , N + C-SH2 and C-SH2 interact with both PROTEIN beta and PROTEIN beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN beta .
0	An PROTEIN complex containing mainly PROTEIN1 and pRb2/p130 ( PROTEIN2-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	Interaction of the PROTEIN subunit of PI 3-kinase with the PROTEIN receptor ( PROTEIN ) and the PROTEIN1 ( PROTEIN2 ) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and PROTEIN1PROTEIN2 and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and Fas-FD8 .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN1PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
1	Overexpression of PROTEIN in MCF7 and BJAB cells induces apoptosis , which , like Fas-induced apoptosis , is blocked by PROTEIN1 , a specific inhibitor of the PROTEIN2 .
0	Interaction of PROTEIN and N+C-SH2 with PROTEIN beta ( delta C-43 ) or PROTEIN beta ( PROTEIN1PROTEIN2 ( delta C-43 ) in which the C-terminal 43 amino acids ( including the YXXM motif ) were deleted , persisted .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and PROTEIN1-FD5 , a mutant of PROTEIN2 possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and Fas-FD8 .
1	The TAFII55-interacting region of PROTEIN1 was localized to its DNA-binding domain , which is distinct from the glutamine-rich activation domains previously shown to interact with Drosophila PROTEIN2 .
1	PROTEIN1 , a novel death domain-containing protein , interacts with the death domain of PROTEIN2 and initiates apoptosis .
0	The putative activation domain of SREBP was shown to bind specifically to amino-terminal domains of recombinant PROTEIN and PROTEIN ( a PROTEIN1PROTEIN2 ( a CBP-related protein ) .
0	PROTEIN also interacted with PROTEIN and PROTEIN1 and with the dominant inhibitors PROTEIN and Bcl-X-S. PROTEIN2 displayed the same pattern of combinatorial interactions with PROTEIN family proteins as PROTEIN .
1	Interactions of the PROTEIN1 protein with itself and other members of the PROTEIN family , including PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , were explored with a yeast two-hybrid system .
0	PROTEIN1 is a lymphoid-specific PROTEIN2 transcription factor that regulates inducible gene expression during T cell activation .
1	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of PROTEIN1/PROTEIN2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN1PROTEIN2 , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	The crystal structure of the PROTEIN1 core domain bound to the PROTEIN protein , which contains an SH3 ( Src homology 3 ) domain and four ankyrin repeats , revealed that ( i ) the SH3 domain binds the L3 loop of PROTEIN2 in a manner distinct from that of previously characterized SH3-polyproline peptide complexes , and ( ii ) an ankyrin repeat , which forms an L-shaped structure consisting of a beta hairpin and two alpha helices , binds the L2 loop of PROTEIN .
0	After T cell activation , the phosphorylation of PROTEIN results in the release of PROTEIN1 , which is correlated temporally with the activation of PROTEIN2-mediated transcription .
0	Overexpression of PROTEIN in MCF7 and BJAB cells induces apoptosis , which , like Fas-induced apoptosis , is blocked by PROTEIN , a specific inhibitor of the PROTEIN1PROTEIN2-induced apoptosis , is blocked by PROTEIN , a specific inhibitor of the interleukin-1 beta-converting enzyme .
0	The findings suggest a model whereby PROTEIN and PROTEIN differentially regulate PROTEIN function , and indicate that requirements for Bcl-2/PROTEIN1PROTEIN2 differentially regulate PROTEIN function , and indicate that requirements for Bcl-2/Bax heterodimerization may be different from those for Bcl-2/Bcl-2 homodimerization .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , PROTEIN1PROTEIN2 , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	The carboxy-terminal region of PROTEIN has previously been shown to interact directly with alpha1 syntrophin , a cytoplasmic component of the PROTEIN1PROTEIN2 , a cytoplasmic component of the dystrophin-glycoprotein complex , by in vitro biochemical studies such as overlay assay or immunoprecipitation .
1	This activation with PROTEIN1 and PROTEIN2 was 4-fold less as compared to PROTEIN beta and was somewhat increased ( 2-fold ) for PROTEIN beta ( delta C-43 ) .
0	PROTEIN is shown to interact with the largest subunit ( PROTEIN ) of human PROTEIN through its central region and with multiple activators -- including PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , adenoviral PROTEIN2 , and human immunodeficiency virus-type 1 PROTEIN proteins -- through a distinct amino-terminal domain .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN1PROTEIN2 activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN1PROTEIN2/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	The results of his3 activation indicated that PROTEIN , N + C-SH2 and C-SH2 interact with both PROTEIN beta and PROTEIN beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN1PROTEIN2 beta and PROTEIN beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN beta .
1	Activation of PROTEIN1 decreases phosphorylation of PROTEIN2 at sites that negatively regulate its DNA-binding activity .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN1 , which binds PROTEIN and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and PROTEIN2-FD8 .
1	Coassociation of PROTEIN ( PROTEIN1 ) with PROTEIN2 on the surface of human T lymphocytes .
0	Coassociation of PROTEIN1 ( PROTEIN2 ) with PROTEIN on the surface of human T lymphocytes .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-PROTEIN1 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-PROTEIN2 and Fas-FD8 .
0	Our data indicate that , in differentiating myocytes , one mechanism through which PROTEIN induces permanent cell cycle arrest involves PROTEIN1PROTEIN2 induces permanent cell cycle arrest involves PROTEIN upregulation and suppression of the proliferation-associated cdks-containing PROTEIN complexes formation .
0	The results of his3 activation indicated that PROTEIN , N + C-SH2 and C-SH2 interact with both PROTEIN beta and PROTEIN beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN1PROTEIN2 and PROTEIN beta , whereas N-SH2 and SH3 + N-SH2 interact only with PROTEIN beta .
0	PROTEIN also interacted with PROTEIN and PROTEIN1 and with the dominant inhibitors PROTEIN and Bcl-X-S. PROTEIN displayed the same pattern of combinatorial interactions with PROTEIN2 family proteins as PROTEIN .
0	Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ( PROTEIN ) protein PROTEIN and the pocket proteins PROTEIN , PROTEIN1 and PROTEIN2/p130 .
0	The carboxy-terminal region of PROTEIN has previously been shown to interact directly with alpha1 syntrophin , a cytoplasmic component of the PROTEIN1PROTEIN2 has previously been shown to interact directly with alpha1 syntrophin , a cytoplasmic component of the dystrophin-glycoprotein complex , by in vitro biochemical studies such as overlay assay or immunoprecipitation .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( PROTEIN1PROTEIN2-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	Overexpression of PROTEIN in MCF7 and BJAB cells induces apoptosis , which , like PROTEIN1PROTEIN2 in MCF7 and BJAB cells induces apoptosis , which , like Fas-induced apoptosis , is blocked by PROTEIN , a specific inhibitor of the interleukin-1 beta-converting enzyme .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN and Fas-PROTEIN1 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and PROTEIN2-FD8 .
0	Comparison of messenger RNA gene expression of extracellular matrix proteins ( procollagen I , PROTEIN , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN1PROTEIN2 , PROTEIN , hyaluronic acid synthase 2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) across cell passages ( 3 , 4 , 5 , 6 , 10 , and 12 fornormal laminapropria and 3 , 4 , 5 , 6 , and 10 for tracheal scar ) revealed varied growth patterns .
0	Withdrawal from the cell cycle of differentiating myocytes is regulated by the myogenic basic helix-loop-helix ( PROTEIN ) protein PROTEIN1PROTEIN2 ( PROTEIN ) protein PROTEIN and the pocket proteins PROTEIN , PROTEIN and pRb2/p130 .
0	Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/PROTEIN1PROTEIN2-MyoD ( ER-MyoD ) chimerae , we found that estrogen directed PROTEIN activation prevents the reassociation of cyclinA/cdk2 to the PROTEIN containing complex following serum stimulation and this correlates with suppression of PROTEIN activity and the inability of cells to re-enter the cell cycle .
0	An PROTEIN complex containing mainly PROTEIN and PROTEIN1/p130 ( PROTEIN2-G0/G1 complex ) appears when DNA synthesis arrests , replacing the cyclinA/cdk2 containing PROTEIN complex of proliferating myoblasts ( E2F-G1/S complex ) .
0	Using the cytoplasmic domain of PROTEIN in the yeast two-hybrid system , we have identified a novel interacting protein , PROTEIN , which binds PROTEIN1 and Fas-FD5 , a mutant of PROTEIN possessing enhanced killing activity , but not the functionally inactive mutants Fas-LPR and PROTEIN2-FD8 .
